Kiran Mazumdar-led Biocon Biologics is in the midst of a fund raising blitzkrieg in 2020. It recently sealed a deal with Wall Street powerhouse Goldman Sachs and now it’s in talks for a fourth fund raise.
According to a report by moneycontrol.com, post the Goldman Sachs deal, Biocon Biologics is now in talks with ADQ for a fresh shot of funds.
ADQ is a sovereign wealth fund owned by Abu Dhabi government. ADQ is looking to invest up to 100 million dollars in Biocon Biologics and due diligence is underway.
Watch this video for more.